HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer.

HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer.

Arch Pathol Lab Med. 2016 Aug;140(8):741

Authors: Gulbahce HE, Factor R, Geiersbach K, Downs-Kelly E

PMID: 27472230 [PubMed - as supplied by publisher]

from Head and Neck on PubMed via xlomafota13 on Inoreader http://ift.tt/2aCcT0q
via IFTTT

http://ift.tt/2ayocFY